The Myasthenia Alliance Australia is partnering with OPTIMAL NHMRC Centre for Research Excellence in improving immunoglobulin use, and we invite you to join our upcoming webinar on Myasthenia Gravis. 

Date: Monday 24th November 2025

Time:

• Eastern daylight-saving states (NSW, VIC, TAS, ACT): 3:00 – 4:30 PM
• Queensland: 2:00 – 3:30 PM
• South Australia: 2:30 – 4:00 PM
• Northern Territory: 1:30 – 3:00 PM
• Western Australia: 12:00 – 1:30 PM

This session will bring together clinicians, researchers, and people with lived experience to discuss current understanding of Myasthenia Gravis, insights from national research on immunoglobulin therapy in Myasthenia Gravis, and how patient preferences can help shape future care. 

This is a great example of different stakeholders coming together to provide resources and information for a wide audience, while also raising awareness about Myasthenia. As a patient, you can learn more about current research and how it has an impact on our healthcare and the therapies we can access. 

For more information and to register, scan the QR code on the flyer or click here.

Please note this webinar will not be recorded, so we encourage you to join live to make the most of this opportunity to hear from the speakers and ask questions during the Q&A session.

View the program:

Please feel free to share this invitation with your networks or anyone who may be interested – all are welcome to attend.

We look forward to your participation!